East Central Indiana Radiation Oncology entered the industry of Health Practitioners in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621399, which describes it as a Health Practitioners. For further clarification, the SIC classifies this business under the code 8049 and described it as a Health Practitioners. The business provides service to the B2B market.
To acquire more information, please contact Charles J Leiphart by calling (765) 747-3148 during business hours. You can also write to the business’ Single Location at 2401 West University Avenue, Muncie, Indiana IN 47303. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | East Central Indiana Radiation Oncology |
Representative: | Charles J Leiphart |
Place of Business: | 2401 West University Avenue, Muncie, IN 47303 |
Contact Number: | (765) 747-3148 |
Type of Service: | Health Practitioners |
SIC Number: | 8049 |
NAICS Number: | 621399 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2001 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
East Central Indiana Radiation Oncology is a company operating from Delaware, Indiana providing professional Health Practitioners and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8049 as Health Practitioners, and with the NAICS code 621399 as Health Practitioners.
With a current employee count of 1 to 4, East Central Indiana Radiation Oncology has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Charles J Leiphart at (765) 747-3148 for related queries, or to locate its Single Location using the coordinates 40.197482,-85.413748.
The Single Location can also be found at the street address 2401 West University Avenue in Muncie, Indiana 47303 and can be engaged online through the company website at , the company Twitter , and Facebook page .